Additionally, ginkgetin-mediated inhibition of the miR-122-5p/GALNT10/Smad3 signaling axis significantly attenuated the migratory capacity of breast cancer MDA-MB-231 cells [44]. Here, SMAD3 is linked to breast carcinoma.